This project proposes a series of in vivo experiments to test and improve the muscle-specific expression of viral vector-delivered micro-, mini-, and full-length dystrophin, as well as a variety of compensatory proteins which will be virally delivered to the dystrophic muscles of mdx4cv mice. Regulatory cassettes of different sizes and expression capabilities have been designed so as to be optimal for packaging into AAV, Lentiviral, and Adenoviral vectors together with therapeutic cDNAs of different sizes. The in vivo studies described in this proposal are critical for establishing the tissue specificity of regulatory gene cassettes, for improving their transcriptional activity in slow muscle fibers, for assuring that the cassettes are not expressed by immune system antigen presenting cells, and for determining whether regulatory cassettes maintain high expression levels for prolonged periods of time. After establishing the adequacy of cassette function in the expression of micro-, mini-, and fuIl-length dystrophin, the most active and tissue-specific regulatory cassettes will be used to over-express single or multiple compensatory proteins such as utrophin, alpha7-integrin, GalNac transferase-2, alpha-dystrobrevin and other members of the dystrophin-glycoprotein complex, as well as to test the beneficial function of dysferlin and other candidate proteins whose compensatory properties have yet to be examined. The overall hypothesis of these studies is that while no single therapeutic protein- especially if vector constraints require its delivery in a micro-form -- may cure DMD, the combinatorial over-expression of proteins that partially substitute for or circumvent aspects of dystrophin's function, and that repair consequences of it absence, may well ameliorate the progression of muscle degeneration, and may change the course of DMD such that the disease phenotype resembles mild forms of Becker muscular dystrophy. This would represent a major improvement for persons with severe DMD.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Program Projects (P01)
Project #
1P01NS046788-01A1
Application #
6803771
Study Section
National Institute of Neurological Disorders and Stroke Initial Review Group (NSD)
Project Start
2004-04-01
Project End
2009-03-31
Budget Start
2004-04-01
Budget End
2005-03-31
Support Year
1
Fiscal Year
2004
Total Cost
$288,477
Indirect Cost
Name
University of Washington
Department
Type
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Whitehead, Nicholas P; Kim, Min Jeong; Bible, Kenneth L et al. (2015) A new therapeutic effect of simvastatin revealed by functional improvement in muscular dystrophy. Proc Natl Acad Sci U S A 112:12864-9
Muir, Lindsey A; Nguyen, Quynh G; Hauschka, Stephen D et al. (2014) Engraftment potential of dermal fibroblasts following in vivo myogenic conversion in immunocompetent dystrophic skeletal muscle. Mol Ther Methods Clin Dev 1:14025
Parker, Maura H; Tapscott, Stephen J (2013) Expanding donor muscle-derived cells for transplantation. Curr Protoc Stem Cell Biol Chapter 2:Unit 2C.4
Gantz, Jay A; Palpant, Nathan J; Welikson, Robert E et al. (2012) Targeted genomic integration of a selectable floxed dual fluorescence reporter in human embryonic stem cells. PLoS One 7:e46971
Parker, Maura H; Loretz, Carol; Tyler, Ashlee E et al. (2012) Activation of Notch signaling during ex vivo expansion maintains donor muscle cell engraftment. Stem Cells 30:2212-20
Himeda, Charis L; Tai, Phillip W L; Hauschka, Stephen D (2012) Analysis of muscle gene transcription in cultured skeletal muscle cells. Methods Mol Biol 798:425-43
Johnson, Eric K; Zhang, Liwen; Adams, Marvin E et al. (2012) Proteomic analysis reveals new cardiac-specific dystrophin-associated proteins. PLoS One 7:e43515
Tai, Phillip W L; Smith, Catherine L; Angello, John C et al. (2012) Analysis of fiber-type differences in reporter gene expression of ?-gal transgenic muscle. Methods Mol Biol 798:445-59
Suga, Tomohiro; Kimura, En; Morioka, Yuka et al. (2011) Muscle fiber type-predominant promoter activity in lentiviral-mediated transgenic mouse. PLoS One 6:e16908
Gonçalves, Manuel A F V; Janssen, Josephine M; Nguyen, Quynh G et al. (2011) Transcription factor rational design improves directed differentiation of human mesenchymal stem cells into skeletal myocytes. Mol Ther 19:1331-41

Showing the most recent 10 out of 32 publications